Chemoinformaics analysis of 14-HYDROXY-10,14-DIMETHYLHEXADECAN-2-ONE
| Molecular Weight | 284.484 | nRot | 13 |
| Heavy Atom Molecular Weight | 248.196 | nRig | 6 |
| Exact Molecular Weight | 284.272 | nRing | 0 |
| Solubility: LogS | -4.126 | nHRing | 0 |
| Solubility: LogP | 4.04 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 56 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 55.6685 |
| nHD | 1 | BPOL | 36.9835 |
| QED | 0.462 |
| Synth | 2.624 |
| Natural Product Likeliness | 1.663 |
| NR-PPAR-gamma | 0.953 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.911 |
| Pgp-sub | 0.003 |
| HIA | 0.003 |
| CACO-2 | -4.543 |
| MDCK | 0.000037 |
| BBB | 0.764 |
| PPB | 0.952347 |
| VDSS | 0.741 |
| FU | 0.0405212 |
| CYP1A2-inh | 0.448 |
| CYP1A2-sub | 0.396 |
| CYP2c19-inh | 0.233 |
| CYP2c19-sub | 0.164 |
| CYP2c9-inh | 0.163 |
| CYP2c9-sub | 0.919 |
| CYP2d6-inh | 0.035 |
| CYP2d6-sub | 0.209 |
| CYP3a4-inh | 0.346 |
| CYP3a4-sub | 0.175 |
| CL | 7.004 |
| T12 | 0.567 |
| hERG | 0.037 |
| Ames | 0.017 |
| ROA | 0.015 |
| SkinSen | 0.947 |
| Carcinogencity | 0.415 |
| EI | 0.901 |
| Respiratory | 0.321 |
| NR-Aromatase | 0.03 |
| Antiviral | Yes |
| Prediction | 0.646287 |